Prognostic Value of Procalcitonin and C-Reactive Protein in 1608 Critically Ill Patients with Severe Influenza Pneumonia.
dc.contributor.author | Carbonell, Raquel | |
dc.contributor.author | Moreno, Gerard | |
dc.contributor.author | Martín-Loeches, Ignacio | |
dc.contributor.author | Gomez-Bertomeu, Frederic | |
dc.contributor.author | Sarvisé, Carolina | |
dc.contributor.author | Gómez, Josep | |
dc.contributor.author | Bodí, María | |
dc.contributor.author | Díaz, Emili | |
dc.contributor.author | Papiol, Elisabeth | |
dc.contributor.author | Trefler, Sandra | |
dc.contributor.author | Nieto, Mercedes | |
dc.contributor.author | Estella, Angel | |
dc.contributor.author | Jiménez Herrera, María | |
dc.contributor.author | Vidal Cortés, Pablo | |
dc.contributor.author | Guardiola, Juan José | |
dc.contributor.author | Solé-Violán, Jordi | |
dc.contributor.author | Rodríguez, Alejandro | |
dc.date.accessioned | 2025-01-07T12:55:55Z | |
dc.date.available | 2025-01-07T12:55:55Z | |
dc.date.issued | 2021-03-26 | |
dc.description.abstract | Background: Procalcitonin (PCT) and C-Reactive protein (CRP) are well-established sepsis biomarkers. The association of baseline PCT levels and mortality in pneumonia remains unclear, and we still do not know whether biomarkers levels could be related to the causative microorganism (GPC, GNB). The objective of this study is to address these issues. Methods: a retrospective observational cohort study was conducted in 184 Spanish ICUs (2009-2018). Results: 1608 patients with severe influenza pneumonia with PCT and CRP available levels on admission were included, 1186 with primary viral pneumonia (PVP) and 422 with bacterial Co-infection (BC). Those with BC presented higher PCT levels (4.25 [0.6-19.5] versus 0.6 [0.2-2.3]ng/mL) and CRP (36.7 [20.23-118] versus 28.05 [13.3-109]mg/dL) as compared to PVP (p | |
dc.identifier.doi | 10.3390/antibiotics10040350 | |
dc.identifier.issn | 2079-6382 | |
dc.identifier.pmc | PMC8066504 | |
dc.identifier.pmid | 33810263 | |
dc.identifier.pubmedURL | https://pmc.ncbi.nlm.nih.gov/articles/PMC8066504/pdf | |
dc.identifier.unpaywallURL | https://www.mdpi.com/2079-6382/10/4/350/pdf?version=1617936902 | |
dc.identifier.uri | https://hdl.handle.net/10668/25062 | |
dc.issue.number | 4 | |
dc.journal.title | Antibiotics (Basel, Switzerland) | |
dc.journal.titleabbreviation | Antibiotics (Basel) | |
dc.language.iso | en | |
dc.organization | SAS - Hospital Universitario de Jerez de la Frontera | |
dc.pubmedtype | Journal Article | |
dc.rights | Attribution 4.0 International | |
dc.rights.accessRights | open access | |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
dc.subject | C-Reactive protein | |
dc.subject | Gram negative bacilli | |
dc.subject | Gram-positive cocci | |
dc.subject | mortality | |
dc.subject | pneumonia | |
dc.subject | procalcitonin | |
dc.title | Prognostic Value of Procalcitonin and C-Reactive Protein in 1608 Critically Ill Patients with Severe Influenza Pneumonia. | |
dc.type | research article | |
dc.type.hasVersion | VoR | |
dc.volume.number | 10 |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- PMC8066504.pdf
- Size:
- 1.22 MB
- Format:
- Adobe Portable Document Format